Related Experiment Video
Updated: Mar 9, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Successful treatment of donor-derived hepatitis C infection in a lung transplant recipient
Nicole Theodoropoulos1, Bryan A Whitson2, Stanley I Martin3
1Division of Infectious Diseases & Immunology, Department of Medicine, UMass Memorial Medical Center, Worcester, MA, USA.
Abstract:
Data are limited regarding the use of direct-acting antivirals for treatment of hepatitis C infection post lung transplant, especially in a donor-derived infection. We present a case of a lung transplant recipient with donor-derived hepatitis C that was successfully treated with a 12-week regimen of simeprevir and sofosbuvir. This case reiterates the importance of screening recipients of increased-risk donor organs for disease transmission and the value of early therapy.

